Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Becton Dickinson and Co (BDX) vs Xylem, Inc. (XYL) Price & Performance

Becton Dickinson and CoTrade
Xylem, Inc.Trade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs Xylem, Inc. — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Xylem, Inc. trades at $123.19 (market cap $28.76B). The key difference: Becton Dickinson and Co is the larger of the two by market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.

BDXXYL
Market Cap
$49.41B$28.76B
Sector
HealthIndustrials
52-Week High
$185.39$152.95
52-Week Low
$138.62$106.34
Enterprise Value
$65.51B$30.54B
Dividend Yield
2.32%1.4%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX

About Xylem, Inc.

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.

Read more on XYL